MES to Manufacturing Intelligence: Powering the Autonomous Pharma Factory
At Pharma MES USA, we will showcase how the shift from traditional MES toward manufacturing intelligence is shaping the future of the autonomous pharma factory. Our theme, MES as a digital backbone, highlights how modern MES platforms connect process control, quality systems like QMS and LIMS, supply chain platforms and AI-driven insights to unlock real operational value.
We will share how greenfield MES programs create space to rethink manufacturing optimization and intelligence with a long-term view for the next decade and how enterprises keep compliance built into design through every stage rather than adding it later. Through this approach, we support pharma manufacturers in achieving resilient, compliant and insight-driven operations on a scale.
Future Forward Perspectives
The evolution of MES: From execution layer to manufacturing intelligence platform driven by AI
MES/MOM adoption needs to keep pace with the industry, with AI infused at every stage. AI and automation are accelerating MOM adoption in a nonlinear, error-proofing way. The opportunity now is to build intelligent AI models on top of MOM that make production self-aware, predictive and self-healing. Data and AI technologies in the cloud will play a big role in both existing operations and brownfield and greenfield expansions.
Vice President, Head - Digital Manufacturing, Engineering R&D Services
How can Agentic automation and contextualized data unlock MOM business value
Enterprises can unlock far greater value from MOM through better adoption, stronger use of dormant data and by adding an agentic layer that brings context and elevates user experience. We will share insights on the real UNS proposition and the business value it delivers.
Senior Director - Digital Manufacturing Leader - Life Sciences, Engineering R&D Services
Engineering and Industry Leaders at the Event
Meet us at Pharma MES USA 2026
